DekaBank Deutsche Girozentrale - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q1 2023$493
+11.0%
59,6000.0%0.00%0.0%
Q4 2022$444
-99.9%
59,6000.0%0.00%0.0%
Q3 2022$400,000
-16.7%
59,6000.0%0.00%0.0%
Q2 2022$480,000
-42.0%
59,6000.0%0.00%
-50.0%
Q1 2022$827,000
-41.5%
59,600
+10.0%
0.00%
-33.3%
Q4 2021$1,414,000
+1.4%
54,200
+26.0%
0.00%
-25.0%
Q3 2021$1,395,000
-22.3%
43,0000.0%0.00%
-20.0%
Q2 2021$1,795,000
+10.3%
43,0000.0%0.01%0.0%
Q1 2021$1,627,000
-35.9%
43,0000.0%0.01%
-50.0%
Q4 2020$2,539,000
+33.6%
43,000
+7.2%
0.01%
+25.0%
Q3 2020$1,900,00040,1000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 17,332,191$535,565,00013.21%
TIGER MANAGEMENT L.L.C. 1,115,411$34,466,00013.06%
VIKING GLOBAL INVESTORS LP 38,406,607$1,186,764,0006.18%
Senator Investment Group LP 5,113,085$146,145,0003.67%
Casdin Capital, LLC 463,125$14,310,562,0001.48%
Graticule Asia Macro Advisors LLC 356,326$11,010,0000.86%
Ratan Capital Management LP 41,272$1,275,0000.67%
Rock Springs Capital Management LP 545,000$16,841,0000.67%
MYDA Advisors LLC 34,000$1,051,0000.48%
Aristotle Atlantic Partners, LLC 50,459$1,559,0000.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders